CBD combined with ginseng compound in nanoparticles achieved 82% tumor inhibition in breast cancer mice | Research

The takeaway

CBD co-loaded with a ginseng compound (PPD) into liposomal nanoparticles showed dose-dependent anti-tumor effects in breast cancer mice, achieving 82.2% tumor inhibition with good tolerability.

Cancer researchers and those interested in cannabinoid-based anti-tumor therapies.

82.2% tumor inhibition rate with good tolerance

What the researchers found

CBD and 20(S)-Protopanaxadiol (PPD, from ginseng) co-loaded into liposomes (mean particle size 138.8 nm) achieved 82.2% tumor inhibition in mice bearing breast tumors (4T1 cells) with good tolerance. However, adding glucose-targeting modifications did not significantly improve the results.

Why it matters

CBD has shown anti-tumor potential but faces delivery challenges. Combining it with PPD in nanoparticles may enhance efficacy while maintaining tolerability, and CBD may also address cancer-associated pain, anxiety, and cachexia.

The numbers in context

Liposome size: 138.8 nm. Tumor inhibition rate: 82.2% with good dose dependence. In vivo mouse model using 4T1 breast cancer cells.

How the study worked

Liposomal nanoparticle formulation study with in vivo testing in BALB/c mice bearing 4T1 breast tumors. Compared CBD-PPD liposomes to glycosyl-modified versions targeting GLUT1 receptors on tumor cells.

What this study cannot tell us

Mouse model only. Single tumor type (4T1). Glucose-targeting modification did not improve results. Human pharmacokinetics and tumor penetration would differ from mice.

How to read the evidence

Animal study with a single tumor model. Promising formulation approach but far from clinical application.

When this study was published

Published in 2022.

The bigger picture

CBD's unique profile of anti-tumor effects plus symptom management (pain, anxiety, cachexia) makes it a particularly interesting candidate for cancer treatment, especially when delivery challenges are overcome.

Questions still open

Would CBD-PPD liposomes work against other cancer types? Can nanoparticle delivery achieve therapeutic CBD concentrations in human tumors?

Common questions

Why combine CBD with a ginseng compound?

PPD (from ginseng) was added to create a synergistic anti-tumor effect with CBD. The combination in liposomal nanoparticles achieved higher tumor inhibition than what either compound typically achieves alone.

Could this be used to treat breast cancer?

Not yet. This was an animal study showing proof of concept. Human clinical trials would need to confirm safety, efficacy, and optimal dosing before clinical use.

Read the original research

Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD).

Pharmaceutics, 14(8)

View on PubMed ↗Publisher’s paper ↗

Citation

Fu, Jingxin; Zhang, Kunfeng; Lu, Likang; Li, Manzhen; Han, Meihua; Guo, Yifei; Wang, Xiangtao. (2022). Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD).. Pharmaceutics, 14(8). https://doi.org/10.3390/pharmaceutics14081533